SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 245 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is 0.93 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,532,003 | -9.2% | 200,653 | -1.0% | 0.06% | +5.2% |
| Q2 2023 | $6,091,749 | -44.9% | 202,653 | -33.6% | 0.06% | -49.1% |
| Q1 2023 | $11,053,012 | -52.7% | 305,079 | -53.5% | 0.11% | -55.3% |
| Q4 2022 | $23,389,960 | -1.7% | 655,732 | -6.7% | 0.26% | -8.6% |
| Q3 2022 | $23,790,000 | +33.5% | 702,808 | +14.0% | 0.28% | +36.1% |
| Q2 2022 | $17,826,000 | -15.3% | 616,375 | -5.4% | 0.20% | +7.3% |
| Q1 2022 | $21,052,000 | +16.9% | 651,355 | +5.4% | 0.19% | +34.5% |
| Q4 2021 | $18,012,000 | +16.6% | 617,701 | +6.7% | 0.14% | +17.4% |
| Q3 2021 | $15,444,000 | -38.6% | 579,073 | -29.1% | 0.12% | -34.2% |
| Q2 2021 | $25,147,000 | +24.8% | 816,731 | +6.1% | 0.18% | +21.1% |
| Q1 2021 | $20,146,000 | – | 769,523 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 7,641,250 | $107,207,000 | 7.06% |
| HealthInvest Partners AB | 782,746 | $10,982,000 | 6.50% |
| KOPP INVESTMENT ADVISORS LLC | 729,960 | $10,241,000 | 5.51% |
| Murphy Michael R | 1,028,304 | $14,427,000 | 4.96% |
| Opaleye Management Inc. | 460,000 | $6,454,000 | 3.18% |
| ASHFORD CAPITAL MANAGEMENT INC | 511,244 | $7,173,000 | 1.68% |
| Bruce & Co., Inc. | 394,581 | $5,535,000 | 1.42% |
| AlphaOne Investment Services, LLC | 235,065 | $3,297,000 | 1.40% |
| Ranger Investment Management | 1,560,453 | $21,893,000 | 1.23% |
| NORTHPOINTE CAPITAL LLC | 584,753 | $8,204,000 | 1.07% |